On one hand, IL-1RA is known to bind to the IL-1 receptor, thereby preventing the binding of both IL-1α and IL-1β, and it has been proposed that inhibiting the IL-1 pathway may prevent the development of various CVDs, including atherosclerosis, MI, and heart failure (7, 44). Here, IL1B is linked to myocardial infarction.